On October 26, 2023, the III International Pharmaceutical Forum “Global Pharm” was held in Astana. During the forum, a Memorandum of Cooperation was concluded between the Ministry of Health of the…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…